Skip to content

Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis

Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis: the Role of Flow Experience and Mindfulness

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06403631
Acronym
MindFlowMS
Enrollment
361
Registered
2024-05-08
Start date
2023-11-06
Completion date
2026-02-28
Last updated
2026-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

The overall goal of this observational study is to learn about the psychological resources of mindfulness and flow experience available to persons newly diagnosed with multiple sclerosis (MS). The primary study aim will be to analyze the relation of flow and mindfulness with mental health among individuals who received an MS diagnosis within the last year. Secondary aims will be to analyze the daily activities preferentially associated with flow, and to evaluate possible changes in daily flow retrieval. Participants will answer questionnaires measuring flow, mindfulness, positive mental health, anxiety and depression at project start and 6 months later.

Detailed description

The period following Multiple Sclerosis (MS) diagnosis is extremely important to identify and mobilize psychological resources that can support mental health, help cope with challenges, and lead to disease acceptance. Capitalizing on previous studies attesting to the crucial role of attentional skills in disease adjustment, the overall goal of this project is to jointly investigate flow experience and mindfulness as potential resources supporting mental health among newly diagnosed persons. While mindfulness has been widely investigated in relation to MS, flow has been rarely explored. Both constructs are rewarding mental states involving focused attention on the present moment and perceived control over the situation. Yet, they also present relevant differences. Mindfulness is characterized by reflective awareness, while flow by loss of selfconsciousness. Mindfulness can generate initial heightened unpleasant feelings, and its cultivation requires constant practice; instead, flow does not require intensive training and it is reported in association with ordinary daily situations and activities. In light of these differences, it may be suitable to promote flow, or a combination of flow and mindfulness, at the initial stages of MS, as newly diagnosed persons require immediate psychological support and need to find a sense of continuity in life. The primary study aim will be to analyze the relation of flow and mindfulness with mental health among individuals who received an MS diagnosis within the last year. Secondary aims will be to analyze the daily activities preferentially associated with flow, and to evaluate possible changes in daily flow retrieval. Data will be gathered longitudinally from participants recruited in MS centers across Italy. Participants will fill in online questionnaires measuring flow, mindfulness, positive mental health, anxiety and depression. The questionnaires, including both scaled and open-ended questions, will be proposed at the project start (T1) and 6 months later (T2). Hierarchical regressions and qualitative analyses will be conducted to assess study aims. Both flow and mindfulness are expected to independently contribute to participants' mental health. However, considering its usual occurrence in daily contexts, flow is expected to provide a more relevant contribution than mindfulness, and to play a moderating role in the relation between mindfulness and mental health. The investigators also expect that participants will primarily retrieve flow in productive and leisure activities, and that fewer participants would find flow occasions in their daily life after the diagnosis.

Interventions

OTHERobservational

Data will be gathered longitudinally from participants newly diagnosed with multiple sclerosis. Participants will fill in online questionnaires measuring flow, mindfulness, positive mental health, anxiety and depression. The questionnaires, including both scaled and open-ended questions, will be proposed at the project start (T1) and 6 months later (T2).

Sponsors

Marta Bassi
Lead SponsorOTHER
Italian Multiple Sclerosis Foundation
CollaboratorOTHER
Università Vita-Salute San Raffaele
CollaboratorOTHER
Azienda Ospedaliera Sant'Anna
CollaboratorOTHER
San Luigi Gonzaga Hospital
CollaboratorOTHER
University of Florence
CollaboratorOTHER
University of Bari
CollaboratorOTHER
University of Cagliari
CollaboratorOTHER
Azienda Ospedaliera San Camillo Forlanini
CollaboratorOTHER
University of Catania
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* age 18-50 * clinically-definite MS diagnosed (with McDonald's revised criteria) within the previous 12 months * steroid treatment for at least 1 month * written informed consent

Exclusion criteria

* neurological disorders other than MS * psychiatric disorders * severe physical impairment (EDSS=\>8) * pregnancy * current or previous attendance in Mindfulness Based Interventions or Acceptance and Commitment Therapy * severe cognitive impairment in comprehension, attention and execution of inferential-logical operations which could interfere with the ability to fill in questionnaires (equivalent scores 0-1 at Progressive Raven Matrices; score \<11.3 at the visual comprehension of sentences subtest of the Aphasia Neuropsychological Test; score \<37.9 at Symbol Digit Modalities Test; and score \<93.1 at the Brief Test of Intelligence)

Design outcomes

Primary

MeasureTime frameDescription
Positive mental health (Mental Health Continuum Short Form)The questionnaires will be administered at T1 (within 12 months from diagnosis disclosure) and at T2 (after 6 months)Mental Health Continuum Short Form, min-max sum values: 0-70, higher scores indicating higher mental health
Anxiety (subscale of the Hospital Anxiety and Depression Scale)The questionnaires will be administered at T1 (within 12 months from diagnosis disclosure) and at T2 (after 6 months)Subscale of the Hospital Anxiety and Depression Scale, min-max sum values: 0-21, higher scores indicating higher anxiety levels
Depression (subscale of the Hospital Anxiety and Depression Scale)The questionnaires will be administered at T1 (within 12 months from diagnosis disclosure) and at T2 (after 6 months)Subscale of the Hospital Anxiety and Depression Scale, min-max sum values: 0-21, higher scores indicating higher depression levels

Secondary

MeasureTime frameDescription
Flow-related activities (Flow Questionnaire)The questions will be administered at T1 (within 12 months from diagnosis disclosure) and at T2 (after 6 months)Flow Questionnaire: open-ended questions on activities associated with flow experience
Flow occurrence (Flow Questionnaire)The questionnaire will be administered at T1 (within 12 months from diagnosis disclosure) and at T2 (after 6 months)Flow Questionnaire: dummy variable for flow presence (1) vs. absence (0)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 24, 2026